EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Hemoglobin, Albumin, Lymphocyte Count, and Platelet (HALP) Score on Survival of Patients with Metastatic Thyroid Cancer Treated with Tyrosine Kinase Inhibitors

Hikmet Öztop iD, Fazıl Çağrı Hunutlu iD, Selin İldemir Ekizoğlu iD, Özen Öz Gül, Soner Cander iD, Ahmet Bilgehan Şahin

Journal of Clinical Medicine · 16.02.2025 · 14 (4) · 1306

DOI: 10.3390/jcm14041306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 16.02.2025. Verfasst von Hikmet Öztop und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tyrosine kinase inhibitors (TKIs) are crucial for improving the survival rates of individuals with metastatic thyroid cancer. Moreover, systemic inflammation and malnutrition are known to negatively affect metastatic thyroid cancer prognosis. Evaluating nutritional status at the start of treatment can improve survival rates.

Purpose

This study investigated the correlation between the hemoglobin, albumin, lymphocyte count, and platelet (HALP) score and prognosis of patients with metastatic thyroid cancer undergoing first-line TKI therapy.

Methods

We retrospectively analyzed data from 44 patients between January 2010 and June 2024. The primary outcomes evaluated in the study were time to treatment failure (TTF) and overall survival (OS); HALP scores were categorized as low (≤29.21) and high (>29.21) based on receiver operating characteristic analysis.

Results

The 1-year survival rate was significantly lower in the low HALP score group compared to the high HALP score group (50% vs. 96.3%). Multivariate Cox regression analysis revealed that low HALP scores, elevated leukocyte counts, and lymphopenia were independent predictors of shorter TTF (HR = 0.272, p = 0.011) and OS (HR = 0.208, p = 0.028).

Conclusions

The results obtained in the present study demonstrate that the HALP score has prognostic significance for patients with metastatic thyroid cancer who are undergoing first-line TKI treatment. In metastatic thyroid cancer patients, interventions focused on improving nutritional status at the start, during initiation, and throughout the TKI treatment may enhance treatment effectiveness. However, further prospective studies involving larger patient cohorts are necessary to validate our results.

Schlagwörter

Stichwörter der Autor:innen

HALP scorenutritionsurvivalthyroid cancertyrosine kinase inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey.
  • Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey.
  • Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey.
  • Division of Oncology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey.

ORCID-Profile: Hikmet Öztop, Fazıl Çağrı Hunutlu, Selin İldemir Ekizoğlu, Soner Cander

Zitieren

APA

Öztop, H., Hunutlu, F. Ç., Ekizoğlu, S. İ., Gül, Ö. Ö., Cander, S., & Şahin, A. B. (2025). Effect of Hemoglobin, Albumin, Lymphocyte Count, and Platelet (HALP) Score on Survival of Patients with Metastatic Thyroid Cancer Treated with Tyrosine Kinase Inhibitors. Journal of Clinical Medicine, 14(4), 1306. https://doi.org/10.3390/jcm14041306

Vancouver

Öztop H, Hunutlu FÇ, Ekizoğlu Sİ, Gül ÖÖ, Cander S, Şahin AB. Effect of Hemoglobin, Albumin, Lymphocyte Count, and Platelet (HALP) Score on Survival of Patients with Metastatic Thyroid Cancer Treated with Tyrosine Kinase Inhibitors. Journal of Clinical Medicine. 2025;14(4):1306. doi:10.3390/jcm14041306

BibTeX
@article{ztop2025,
  author = {Öztop, Hikmet and Hunutlu, Fazıl Çağrı and Ekizoğlu, Selin İldemir and Gül, Özen Öz and Cander, Soner and Şahin, Ahmet Bilgehan},
  title = {Effect of Hemoglobin, Albumin, Lymphocyte Count, and Platelet (HALP) Score on Survival of Patients with Metastatic Thyroid Cancer Treated with Tyrosine Kinase Inhibitors},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {1306},
  doi = {10.3390/jcm14041306}
}
Kostenlos starten →